Render Target: STATIC
Render Timestamp: 2024-10-09T10:04:02.415Z
Commit: f04ddd7fea9fb3592f59f61482fcb94610d25cbe
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

RPL15 (E3X8M) Rabbit mAb #29753

Filter:
  • WB

    Supporting Data

    REACTIVITY H M R
    SENSITIVITY Endogenous
    MW (kDa) 24
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    Species Cross-Reactivity Key:
    • H-Human 
    • M-Mouse 
    • R-Rat 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    RPL15 (E3X8M) Rabbit mAb recognizes endogenous levels of total RPL15 protein. This antibody detects a nonspecific signal around 34 kDa in lysates of some cell lines.

    Species Reactivity:

    Human, Mouse, Rat

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human RPL15 protein.

    Background

    Ribosomal protein L15 (RPL15) is a structural component of the large 60S subunit of the ribosome. Studies show that overexpressed RPL15 protein promotes metastatic growth of breast cancer patient-derived circulating tumor cells. Overexpression of RPL15 was shown to increase translation of other ribosomal proteins of large and small subunits and cell cycle regulators (1). Furthermore, the DNA topoisomerase I inhibitor topotecan binds to RPL15 and suppresses preribosomal subunit formation, which causes ribosomal stress and enhances DNA topoisomerase I-independent antitumor immune activation mediated by damage-associated molecular patterns (2). In addition, RPL15 expression is upregulated in colon cancer cells. RPL15 deficiency leads to ribosomal stress and, therefore, apoptosis of colon cancer cells (3).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.